| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Wesana Health Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.02 |
| 52 Week High | CA$0.075 |
| 52 Week Low | CA$0.005 |
| Beta | -0.40 |
| 11 Month Change | 0% |
| 3 Month Change | -33.33% |
| 1 Year Change | -69.23% |
| 33 Year Change | -99.31% |
| 5 Year Change | n/a |
| Change since IPO | -99.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| WESA.X | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | -0.3% |
| 1Y | -69.2% | 33.8% | 10.3% |
Return vs Industry: WESA.X underperformed the Canadian Pharmaceuticals industry which returned 33.8% over the past year.
Return vs Market: WESA.X underperformed the Canadian Market which returned 10.3% over the past year.
Price Volatility
| WESA.X volatility | |
|---|---|
| WESA.X Average Weekly Movement | 132.8% |
| Pharmaceuticals Industry Average Movement | 12.9% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CA Market | 16.8% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: WESA.X's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine WESA.X's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Daniel Carcillo | www.wesanahealth.com |
Wesana Health Holdings Inc. does not have significant operations. Previously, it was developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. The company is headquartered in Chicago, Illinois.
Wesana Health Holdings Inc. Fundamentals Summary
| WESA.X fundamental statistics | |
|---|---|
| Market cap | CA$699.16k |
| Earnings (TTM) | -CA$2.50m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.3x
P/E RatioIs WESA.X overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WESA.X income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$1.83m |
| Earnings | -US$1.83m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.052 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -60.7% |
How did WESA.X perform over the long term?
See historical performance and comparison